CJC-1295 DAC (2 mg Vial) Dosage Protocol
CJC-1295 DAC Dosage Chart
CJC-1295 DAC is dosed at 2 mg weekly via subcutaneous injection in educational protocols. A 2 mg vial reconstituted with bacteriostatic water yields about 2.0 mg/mL. This information is for research and educational use only.
Reconstitute: Add 1.0 mL bacteriostatic water → 2.0 mg/mL (2,000 mcg/mL) concentration.
Typical weekly dose: 2,000 mcg (2 mg) once weekly — the full vial per injection.
Easy measuring: At 2.0 mg/mL, 1 unit = 0.01 mL = 20 mcg on a U-100 insulin syringe; full dose = 100 units (1.00 mL).
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
CJC-1295 DAC dosage protocols leverage this long-acting growth hormone-releasing hormone (GHRH) analog’s unique albumin-binding technology, which extends its half-life to approximately 6–8 days[1][2]. By stimulating pulsatile growth hormone (GH) release while preserving natural GH rhythms, CJC-1295 DAC can elevate GH levels 2–10 fold and IGF-1 levels 1.5–3 fold in human studies[3]. Benefits may include enhanced muscle growth and recovery, improved fat metabolism, better sleep quality, and anti-aging effects through sustained GH/IGF-1 axis activation[4][5]. This educational protocol presents a once-weekly subcutaneous approach using a practical dilution for clear insulin-syringe measurements.
Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read CJC-1295 DAC Peptide: Benefits, Uses, Side Effects, Dosage, and Research.
Standard Weekly Approach (1 mL = 2.0 mg/mL)
Weeks 1–12
2,000 mcg (2 mg)
100 units (1.00 mL)
Frequency: Inject once weekly subcutaneously, preferably in the evening before bed to align with natural nocturnal GH surges[6]. The peptide’s extended half-life (~6–8 days) supports weekly administration without significant loss of activity between doses[1].
Reconstitution Steps
Draw 1.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming or direct stream onto the powder.
Gently swirl/roll until dissolved (do not shake vigorously).
Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Supplies Needed
Plan based on an 8–12 week weekly protocol.
Peptide Vials (CJC-1295 DAC, 2 mg each):
8 weeks: 8 vials (1 vial/week)
12 weeks: 12 vials (1 vial/week)
Insulin Syringes (U-100, 1 mL capacity):
Per week: 1 syringe
8 weeks: 8 syringes
12 weeks: 12 syringes
Bacteriostatic Water (10 mL bottles): Use 1.0 mL per vial for reconstitution.
8 weeks (8 vials): 8 mL → 1 × 10 mL bottle
12 weeks (12 vials): 12 mL → 2 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each week.
Per week: 2 swabs
8 weeks: 16 swabs → recommend 1 × 100-count box
12 weeks: 24 swabs → recommend 1 × 100-count box